Update on Vedolizumab in IBD: What have we learned?

In this video, Dr Bruce Sands discusses the current role of JAK inhibitors for the treatment of IBD and whether or not gastroenterologists should be concerned with adverse events.

James Matera, DO, discussed the differences between NASH and NAFLD, the epidemiology and clinical presentation, and treatment options.

In this video, Stewart Tepper, MD, discusses the findings from his recent trial on the long-term efficacy of erenumab among patients with chronic migraine with or without acute medication overuse, and how...